Atsushi Yoshida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Atsushi Yoshida has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Hirohisa Endo
Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan
1 shared publicationKazuoki Osumi
Otsuka Assay Laboratories, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan
1 shared publicationSatoshi Kimura
Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan
1 shared publication- Shigemi Hitomi
Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan
1 shared publication - Shinichi Oka
Japan Institute for Health Security, Tokyo 162-8655, Japan
1 shared publication Takafumi Fukui
Otsuka Assay Laboratories, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 15 November 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (10) , 1756-1761
Diagnosis and Monitoring of Human Cytomegalovirus Diseases in Patients with Human Immunodeficiency Virus Infection by Use of a Real‐Time PCR Assay
We used a real-time PCR assay to measure human cytomegalovirus (HCMV) DNA load in whole blood and plasma of 70 patients who were infected with human immunodeficiency virus type 1. Break points of 3.0 × 103 copies/mL in whole blood and 1.0 × 103 copies/mL in plasma were well-correlated with the existence of definite HCMV disease (sensitivity, 93% and 86%; specificity, 89% and 85%; positive predictive value, 70% and 63%; and negative predictive value, 98% and 95%, respectively). In patients with + T lymphocytes, positive predictive values increased to 78% and 71%, respectively. The viral loads of all patients who received anti-HCMV therapy declined to ⩽ 2.0 × 102 copies/mL in parallel with the improvement of clinical symptoms. These findings show that the HCMV DNA load quantified with our method is a useful tool for diagnosis of HCMV diseases and for monitoring the disease activity in patients infected with HIV-1.
- 15 November 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (10) , 1756-1761
Open AccessDiagnosis and Monitoring of Human Cytomegalovirus Diseases in Patients with Human Immunodeficiency Virus Infection by Use of a Real‐Time PCR Assay
We used a real-time PCR assay to measure human cytomegalovirus (HCMV) DNA load in whole blood and plasma of 70 patients who were infected with human immunodeficiency virus type 1. Break points of 3.0 × 103 copies/mL in whole blood and 1.0 × 103 copies/mL in plasma were well-correlated with the existence of definite HCMV disease (sensitivity, 93% and 86%; specificity, 89% and 85%; positive predictive value, 70% and 63%; and negative predictive value, 98% and 95%, respectively). In patients with + T lymphocytes, positive predictive values increased to 78% and 71%, respectively. The viral loads of all patients who received anti-HCMV therapy declined to ⩽ 2.0 × 102 copies/mL in parallel with the improvement of clinical symptoms. These findings show that the HCMV DNA load quantified with our method is a useful tool for diagnosis of HCMV diseases and for monitoring the disease activity in patients infected with HIV-1.